Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population-Reference-Cited by-同舟云学术

Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population

Published:2018-01-30 Issue:3 Volume:67 Page:847-857
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Sikavi Cameron¹,Chen Phillip H.²,Lee Alex D.²,Saab Elena G.²,Choi Gina²³,Saab Sammy²³

Affiliation:

1. Department of Medicine at Harbor; University of California at Los Angeles Medical Center; Torrance CA

2. Department of Surgery; University of California at Los Angeles; Los Angeles CA

3. Department of Medicine; University of California at Los Angeles; Los Angeles CA

Publisher

Wiley

Subject

Hepatology

Reference70 articles.

1. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence;Mohd Hanaah;Hepatology,2013

2. UNAIDS How AIDS changed everything-MDG6: 15 years, 15 lessons of hope from the AIDS response http://www.unaids.org/en/resources/documents/2015/MDG6_15years-15lessonsfromtheAIDSresponse 2017

3. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis;Platt;Lancet Infect Dis,2016

4. Viral hepatitis and HIV coinfection;Sulkowski;J Hepatol,2008

5. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration;Smith;Lancet,2014

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Era of DAAs: Assessing the Patients’ Characteristics, Clinical Impact, and Emergence of Comorbidities in HIV/HCV-Coinfected versus HIV-Infected Individuals;Journal of Clinical Medicine;2024-07-04

2. Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis;Hepatology;2024-03-07

3. The Era of DAAs: Assessing the Clinical Impact and Emergence of Comorbidities in HIV/HCV-Coinfected versus HIV-Infected Individuals;2024-01-17

4. Hepatitis C: Updates in Epidemiology and for Treatment with Direct-Acting Antivirals;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

5. Hepatitis C Risk Prediction Based on Adaboost;Highlights in Science, Engineering and Technology;2023-07-04